Castration resistant prostate cancer - Globe Thesis

Keyword [Castration resistant prostate cancer] Result: 61 - 80 \| Page: 4 of 7
61.	Molecular Mechanisms Underlying Sensitization Of Hormone And Chemotherapy-resistant Castration Resistant Prostate Cancer By Novel Drug Conjugate DZ-SIM
62.	The Research On The Effect Of Serum Surface-enhanced Raman Spectroscopy In Predicting The Sensitivity Of Metastatic Castration-resistant Prostate Cancer To Docetaxel Chemotherapy
63.	The Role And Mechanism Of Niclosamide And Its Derivative In Castration-resistant Prostate Cancer
64.	MRI-based Texture Analysis Of The Primary Tumor For The Prediction Of Bone Metastases,therapeutic Evaluation Of Androgen Deprivation Therapy In Prostate Cancer
65.	Knockdown K-Ras Combined Drugs Delays The Malignant Behavior Of Castration-Resistant Prostate Cancer Through PLC?/pKC? Signaling Pathway
66.	NPRL2 Promotes Docetaxel Chemoresistance In Castration Resistant Prostate Cancer Cells By Regulating Autophagy
67.	MiR-30a Inhibits Androgen-independent Growth Of Prostate Cancer Via Targeting MYBL2,FOXD1 And SOX4
68.	The Mechanism Of Medicine For Castration Resistant Prostate Cancer
69.	Effect Of Autophagy Inhibitor On Anticancer Treatment Of Castration-resistant Prostate Cancer
70.	Comparative Analysis Of The Curative Effects Of Abiraterone And Docetaxel In The Treatment Of Castration Resistant Prostate Cancer
71.	Predictors Of Prognosis In Metastatic Castration-naive Prostate Cancer (MCNPC)
72.	The Bioinformatic Analysis Between Hormone Sensitive And Castration Resistant Prostate Cancer
73.	The Expression And Its Clinical Significance Of PALB2 In Castration-resistant Prostate Cancer
74.	The Multifactor Analysis On Clinical Factors And TCM Syndrome Type Of Castration-resistant Prostate Cancer
75.	The Molec?lar Mechanism Of Polyphyllin ? And Enzalutamide On Inhibiting Castration-resistant Prostate Cancer Cell Growth
76.	Analysis Of Prognosis Factors Of Docetaxel In The Treatment Of Metastatic Castration-resistant Prostate Cancer
77.	Treatment Of Metastatic Castration-resistant Prostate Cancer With Abiraterone And Docetaxel
78.	Erastin Downregulates Androgen Receptor And Its Splice Variants In Prostate Cancer
79.	Clinical Factors About Patients With Prostate Cancer Giving ADT Progressing To CRPC
80.	Effect Of NPRL2 On The Sensitivity Of Olaparib In Castration-resistant Prostate Cancer
<<First <Prev Next> Last>> Jump to